Chinese Journal of Pharmacovigilance ›› 2019, Vol. 16 ›› Issue (7): 442-443.
Previous Articles Next Articles
HU Tingting, XU Ting*
Received:
2019-08-06
Revised:
2019-08-06
Online:
2019-07-20
Published:
2019-08-06
CLC Number:
HU Tingting, XU Ting. One Case of Epidermolysis Bullosa Eruption Induced by Clopidogrel Hydrogen Sulfate Tablets[J]. Chinese Journal of Pharmacovigilance, 2019, 16(7): 442-443.
[1] 陈鹏英, 刘乖丽, 杨松, 等. 大疱性表皮松解坏死型药疹211例临床分析[J]. 皮肤病与性病, 2018,40(3):314-316. [2] 包振宁, 邹先彪. 重症药疹的研究进展[J]. 实用皮肤病学杂志,2015,8(2):112-115. [3] 贾王平, 郭代红, 张博, 等.114家医院5411例老年人药品不良反应报告分析[J]. 药物流行病学杂志, 2017,26(3):187-190. [4] 刘秀燕, 郭青梅, 李晓利, 等.197例药品不良反应报告的特点分析[J]. 临床合理用药, 2018,11(10C):107-109. [5] 魏晶, 王瑜歆. 药品与不良反应因果关系评价方法[J]. 中国药物警戒, 2011, 8(10):600-603. [6] 张玲莉, 彭锐, 彭燕. CYP2C19基因多态性与氯吡格雷相关不良反应的Meta分析[J]. 中国医药导报, 2015,12(28):37-42. [7] Nassif A, Bensussan A, Boumsell L, et al.Toxic epidermal necrolysis: effector cells are drug-specific cytotoxic T cells[J]. J Allergy Clin Immunol, 2004, 114(5): 1209-1215. [8] Chung W H, Hung S I, Yang J Y, et al.Granulysin is a key mediator for keratinocyte death in Stevens-Johnson syndrome and toxic epidermal necrolysis[J]. Nat Med, 2008, 14(12):1343-1350. |
[1] | SUN Qiyue, ZHAO Ronghua, GUO Shanshan, BAO Lei, GENG Zihan, LI Shuran, XU Yingli, ZHANG Jingsheng, CUI Xiaolan, SUN Jing. Multiple pharmacological effects of Lingyang Ganmao Oral Liquid [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 127-131. |
[2] | ZHAO Ronghua, SUN Jing, BAO Lei, GENG Zihan, TAO Xiali, ZHANG Jingsheng, PANG Bo, XU Yingli, CAO Shan, LI Shuran, GUO Shanshan, WANG Daohan, CUI Xiaolan. Mechanisms of Gegen Tang granules against viral pneumonia in mice based on immune regulation [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 132-136. |
[3] | BAO Lei, GENG Zihan, LI Shuran, JI Zuen, ZHAO Ronghua, SUN Jing, GUO Shanshan, CUI Xiaolan. The critical role of TRP channels in the progression of viral pneumonia [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 137-140. |
[4] | JIA Jinsheng, LIU Hongliang, WANG Qing, HOU Yongfang, LI Xinling. Evaluation of the relevance of adverse drug reaction based on ERNIE-DPCNN [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 163-166. |
[5] | LI Jiaxin, LIU Huimin, QIAN Wenxiu, MA Ning, SONG Lili, LI Yubo. Nephrotoxic effects and usage of traditional Chinese medicines based on the Traditional Chinese Medicine Systems Toxicology Database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 173-180. |
[6] | FAN Kaikai, WANG Cong, LIU Hongfeng, WANG Xiyong. Effects of clinical pharmacist interventions on usage of alanyl-glutamine injections in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 181-184. |
[7] | ZHANG Jian, FANG Huihua. Applicability of evaluation standards for use of traditional Chinese medicine injections for promoting blood circulation and removing blood stasis [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 185-189. |
[8] | WANG Shan, XIE Bo, LIU Huimin, LI Zhihao. Adverse event signals for celecoxib based on FAERS database [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 190-194. |
[9] | LI Yingfen, HAN Lei. Analysis of 319 cases of adverse drug reaction induced by cerebroprotein hydrolysate for injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 195-198. |
[10] | XU Weijia, PENG Qi, HUANG Haiyu, ZHANG Leijiao, XIAO Hua, WU Xue. 285 cases of adverse drug reaction related to new antineoplastic drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 199-203. |
[11] | GUO Qinghua, PENG Xiaoxiao, ZHU Ping, LIU Xilin, YANG Yinghua, CHEN Zhihai. One case of multiple organ dysfunction syndrome caused by amlodipine overdose [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 204-207. |
[12] | FANG Meilin, ZHENG Huimin, WANG Cunze, WANG Ling, RUAN Junshan. One case of generalized myalgia caused by oxaliplatin [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 208-210. |
[13] | LI Na, GUO Jun, GUO Wenjia, LYU Yinyin, LI Caihong, MU Xiangdong. One case of delayed skin allergic reaction caused by asthma treated with omalizumab injection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 211-212. |
[14] | CAO Guiping, DENG Linlin, ZHU Ganhong, LU Ying, MA Shuang, CHEN Linlin, Liu Lili. One case of severe liver injury caused by Tianma Shouwu tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 216-218. |
[15] | ZHU Ying, SHEN Lu, LI Lan, WU Jianmin, GAO Xiaojie. Adverse reaction monitoring of toothpaste in China under the new regulatory system [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 219-222. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||